RAGE targeted strategies for Alzheimer’s amyloid β peptide induced blood brain barrier dysfunctions
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
RAGE targeted strategies for Alzheimer’s amyloid β peptide induced blood brain barrier dysfunctions ; volume:8 ; number:1 ; day:13 ; month:9 ; year:2013 ; pages:1 ; date:9.2013
Molecular neurodegeneration ; 8, Heft 1 (13.9.2013), 1, 9.2013
- Urheber
-
Askarova, Sholpan
- Beteiligte Personen und Organisationen
-
Tsoy, Andrey
Lee, James C-M
SpringerLink (Online service)
- DOI
-
10.1186/1750-1326-8-S1-P5
- URN
-
urn:nbn:de:1111-2016073072429
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Askarova, Sholpan
- Tsoy, Andrey
- Lee, James C-M
- SpringerLink (Online service)
Ähnliche Objekte (12)
Microvascular and cellular dysfunctions in Alzheimer’s disease: an integrative analysis perspective
Amyloid PET imaging: applications beyond Alzheimer’s disease
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Amyloid blood biomarker detects Alzheimer's disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
Copper binding to the Alzheimer’s disease amyloid precursor protein
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease
Amyloid beta 4-42 in Alzheimer’s disease: Target, Therapy, Mechanism
Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology
Microvascular and cellular dysfunctions in Alzheimer’s disease: an integrative analysis perspective
Amyloid PET imaging: applications beyond Alzheimer’s disease
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Amyloid blood biomarker detects Alzheimer's disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
Copper binding to the Alzheimer’s disease amyloid precursor protein
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease
Amyloid beta 4-42 in Alzheimer’s disease: Target, Therapy, Mechanism
Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology
Microvascular and cellular dysfunctions in Alzheimer’s disease: an integrative analysis perspective
Amyloid PET imaging: applications beyond Alzheimer’s disease
Blood Derived Amyloid Biomarkers for Alzheimer’s Disease Prevention
Amyloid blood biomarker detects Alzheimer's disease
β-amyloid in Alzheimer’s disease initiation and phenotypic diversity
Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
Copper binding to the Alzheimer’s disease amyloid precursor protein
Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease
Amyloid beta 4-42 in Alzheimer’s disease: Target, Therapy, Mechanism